Can Palantir Stock Hit $170 in 2025?
PLTR stock's recent surge past $160 has turned heads, fueled by back-to-back federal deals, sharp commercial adoption, and the Street's bullish price targets. In high-momentum tech plays, analyst commentary can often become a catalyst in itself.
More News from Barchart
Here's What Happened the Last Time Novo Nordisk Stock Was This Oversold
As SoFi Raises 2025 Guidance, Should You Buy, Sell, or Hold SOFI Stock Here?
Earnings Will Be 'Worse Than Expected' for UnitedHealth. How Should You Play UNH Stock Here?
Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now!
Palantir was previously called the 'Messi of AI' by Wedbush analyst Dan Ives, one of Wall Street's loudest tech bulls. Now, Piper Sandler is joining the chorus, calling Palantir an 'AI All-Star' and setting a $170 target, banking on its rare mix of growth and margins to capture massive TAM.
But with rich valuation, extreme volatility baked in, and sky-high expectations, can Palantir really hold its line and hit $170 in 2025?
About Palantir Stock
Founded in 2003, Palantir has grown from a counterterrorism startup into a major force in AI and data analytics. Headquartered in Denver, Colorado, it built platforms like Gotham, Foundry, Apollo, and now AIP, each designed to transform data into strategic action.
The company's deepening role in U.S. defense shows its expanding influence. Today, Palantir powers decisions across governments and industries, redefining how intelligence, security, and enterprise operations are driven by data. With a $372 billion market capitalization, PLTR has officially entered large-cap heavyweight territory.
Palantir's rally has been nothing short of explosive. The stock is up 106% year-to-date (YTD), hitting an all-time high of $160.39 on July 25, making it the top-performing name of the S&P 500 Index ($SPX) in 2025. Its long-term returns are jaw-dropping, with shares up 477% in one year, 777% over two, and a staggering 1,264% across three.
But here's where it gets tricky. With resistance looming at $162 and overbought signals flashing — like the 14-day RSI nearing 70 — the road to Piper Sandler's $170 target may not be smooth. Momentum is hot, but volatility is not far behind.
Palantir's ascent may scream AI dominance, but its valuation paints a riskier picture. Trading at over 400 times forward earnings and 130 times sales, PLTR's valuation towers above even top-tier tech players. While it is branching into the commercial world, Palantir's heart still beats in Washington contracts. For all its potential, the stock's price tag reflects a future not yet fully earned. Reality may demand patience.
Palantir's Q1 Results Exceed Projections
Palantir delivered an impressive first-quarter 2025 earnings report on May 5, pulling in $884 million in revenue, a 39% year-over-year (YOY) jump. But it was the U.S. market that dominated the stage, with stateside revenue soaring 55% to $628 million, powered by 71% growth in the commercial segment and a solid 45% uptick in government business.
The profit line did not disappoint either. Adjusted net income surged nearly 70% to $334.4 million, while EPS amounted to $0.13, crushing expectations with a 62.5% YOY leap. Free cash flow doubled to $370.4 million, with a 42% margin — a clear show of Palantir's operational discipline and financial firepower.
Riding this momentum, management didn't hold back and raised its full-year revenue guidance, now projecting between $3.89 billion and $3.902 billion. U.S. commercial growth alone is now projected to increase by at least 68%, while adjusted operating income is expected to be between $1.71 billion and $1.72 billion.
Palantir is all set to release its fiscal Q2 earnings report on Aug. 4 after the market closes. Management projects revenue for the quarter to be between $934 million and $938 million, while adjusted income from operations is estimated to be between $401 million and $405 million.
Meanwhile, analysts monitoring Palantir expect the company's Q2 EPS to climb 167% YOY to $0.08. Looking further ahead to fiscal 2025, the bottom line is estimated to be around $0.37 per share, up 362% annually, then rise by another 19% to $0.44 per share in fiscal 2026.
What Do Analysts Expect for Palantir Stock?
Wall Street's latest bullish call on Palantir comes from Piper Sandler, and it's turning heads. The brokerage firm initiated coverage on PLTR stock with an 'Overweight' rating and a $170 price target.
The firm views Palantir as a 'one-of-a-kind growth and margin model' that, if proven durable, could hit a $24 billion run rate by 2032 through share gains across two $1 trillion-plus total addressable markets. The analyst calls the company a clear-cut AI secular winner, powering critical infrastructure across both government and commercial sectors.
But the optimism comes with caution. Piper Sandler acknowledges Palantir's history of sharp drawdowns, underscoring the stock's volatility. Despite the bullish thesis, the analyst warns that the valuation is rich and not suited for the faint-hearted. Piper Sandler recommends a 'buy on a drawdown' strategy, urging patience and disciplined exposure as Palantir's growth story unfolds.
Wall Street's take on PLTR stock feels more like a cautious nod than a full-on high five. The stock holds a consensus 'Hold" rating — steady, but far from a Street-wide vote of full confidence. Out of 21 analysts, only four are all-in with a 'Strong Buy" rating, while the majority of 13 analysts sit on the fence with a 'Hold." One analyst leans slightly bearish with a 'Moderate Sell,' while three others do not buy the hype at all, flat-out issuing a 'Strong Sell.'
While PLTR is trading at a premium to its average analyst price target of $110.72, Piper Sandler's Street-high target of $170 suggests that shares can still rise by as much as 9% from current levels.
Final Thoughts on Palantir
Palantir's growth engine has been fueled by a commercial push powered by AIP and its unique boot camp model, which lowers the barrier to adoption. Meanwhile, the $795 million U.S. Army contract and ongoing involvement in projects like the 'Golden Dome' missile defense system keep its government ties rock solid. On the commercial front, new partnerships, like with The Nuclear Company and Tomorrow.io, signal wider adoption.
Still, with sky-high valuations and lingering government dependence, Palantir's path forward is not without friction. However, if it can sustain its dual-pronged growth and prove AIP's long-term value, the company might just justify the hype, though likely not without some bumps along the way.
On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
6 hours ago
- Business Insider
Piper Sandler Sticks to Their Hold Rating for Oscar Health (OSCR)
Piper Sandler analyst Jessica Tassan maintained a Hold rating on Oscar Health yesterday and set a price target of $13.00. The company's shares closed yesterday at $14.93. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Tassan is an analyst with an average return of -6.8% and a 36.08% success rate. Tassan covers the Healthcare sector, focusing on stocks such as Oscar Health, Omnicell, and UnitedHealth. In addition to Piper Sandler, Oscar Health also received a Hold from TR | OpenAI – 4o's Soren Coverra in a report issued on August 8. However, yesterday, Wells Fargo maintained a Sell rating on Oscar Health (NYSE: OSCR). Based on Oscar Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.05 billion and a net profit of $275.27 million. In comparison, last year the company earned a revenue of $2.14 billion and had a net profit of $177.37 million Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OSCR in relation to earlier this year.
Yahoo
11 hours ago
- Yahoo
Palantir Extends SOMPO Collaboration, Targeting $10 Million Annual Efficiency Gains
Palantir Technologies Inc. (NASDAQ:PLTR) shares were trading relatively flat on Tuesday. The company said its long-running collaboration with SOMPO Holdings is expanding under a new multi-year agreement via Palantir Technologies Japan KK. The companies will deepen use of Palantir's Foundry platform across multiple SOMPO subsidiaries, where thousands of staff already rely on the software partners detailed broader adoption in Japan spanning elder care, insurance claims and underwriting workflows. Since 2020, SOMPO has deployed Foundry in care facilities to coordinate services for seniors, streamline required reporting to authorities and surface urgent patient needs more quickly. The insurer is now pushing the platform deeper into its core operations, rebuilding the claims process end-to-end, from fraud screening and triage to continuous monitoring, to lift efficiency and accuracy. SOMPO is also leaning on Palantir-enabled AI agents to evaluate risk and generate recommendations for underwriters. The company expects these tools to improve annual financial results by about $10 million through better decision support and faster cycle times. 'Our partnership with Palantir has brought the best-in-class artificial intelligence software to our subsidiaries across Japan,' said Mikio Okumura, Group CEO of SOMPO Holdings. 'Palantir Foundry continues to grow in importance across all sectors of our business. This software continues to increase our efficiency and profitability and will play a major role in the future of our business.' The latest arrangement marks the second expansion of the relationship, following a $50 million add-on signed in 2023. Palantir said the joint venture in Japan will continue to serve as the hub for future deployments across SOMPO's businesses. Earlier this month, Palantir reported second-quarter revenue of $1.004 billion, beating analyst estimates of $939.71 million. The company reported second-quarter adjusted earnings of 16 cents per share, beating analyst estimates of 14 cents per share. According to Benzinga Pro, PLTR stock has gained over 521% in the past year. Investors can gain exposure to the stock via Direxion Daily PLTR Bull 2X Shares (NASDAQ:PLTU). Price Action: PLTR shares are trading higher by 0.20% to $182.90 premarket at last check Tuesday. Read Next:Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? PALANTIR TECHNOLOGIES (PLTR): Free Stock Analysis Report This article Palantir Extends SOMPO Collaboration, Targeting $10 Million Annual Efficiency Gains originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio


CNBC
16 hours ago
- CNBC
Santoli's Wednesday market wrap-up: A rotation rather than a broad stampede higher
(These are the market notes on today's action by Mike Santoli, CNBC's Senior Markets Commentator. See today's video update from Mike above.) Modest upside follow-through to Tuesday's emphatically broad rally, this time in the form of rotation rather than a broad stampede higher. The laggard groups that are also plays on near-term Fed rate cuts were the standouts today, while the stretched momentum leaders in mega-cap tech settled down: Russell 2000 over Nasdaq-100 , consumer discretionary over tech . Probably shouldn't be viewed as some consequential tidal shift in market character, more a way for a months-long rally to support itself by changing up the muscle groups being flexed. Russell 2000 with an aggressive move, but this one is probably guilty until proven innocent given the years-long range and its habit for racing higher near the tail end of a short-term market advance. Another morning fade in the S & P 500 after a higher opening, something of a recent pattern. But the action looks pretty mechanical so far, a pretty precise filling of the gap left by Tuesday's post-CPI pop: As noted, the market took the higher but far cooler-than-feared CPI as switching on a sequence of green lights ahead: Few known potentially adverse data catalysts and not as many earnings reports to present possible air pockets in individual stocks. Still, July PPI wholesale inflation tomorrow might present a newly blissed-out Street something to ponder, with its feed-through to the Fed's PCE inflation beacon. Pretty strong bid in Treasuries today, compressing yields by 4-5bp across the curve. It's in synch with a global move lower in yields, but suggests a level of comfort with the pileup of dovish Fed Chair candidates and resumed slide in crude oil prices. Some pretty conspicuous softness in key retail-trader risk-appetite "tells," with HOOD and PLTR down, along with recent hot IPOs CRCL and FIG . Nothing decisive but perhaps a sign of fatigue in the fast-money plays. Massive pop in crypto exchange IPO Bullish ( BLSH ) following the script of recent hot deals, though these splashy debuts have shown a pattern of exhausting near-term investor demand soon after their debut date. CRCL is 49% off its high, FIG -43%, ETOR -41%.